Nobel laureate Professor Michael Rosbash and his delegation visited Aiwo Medical

• by EVOMT
• 2022-12-19

On July 10th, Michael, winner of the 2017 Nobel Prize in Medicine and Physiology and academician of the National Academy of Sciences Professor Rosbash, molecular biologist, Yuan Junying, academician of the National Academy of Sciences, Professor Yu Qiang, professor of the School of Medicine of Boston University, leader of the research team of the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences, and provincial and municipal leaders visited IVO Medical for investigation and exchange.

Accompanied by Ms. Wu Qiuting, CEO of Aiwo Medical, we visited the headquarters of Aiwo Medical, and then the two sides held a discussion in the conference room of Aiwo Medical.

Ms. Wu Qiuting, CEO of Aiwo Medical, Zhao Zhiqiang, Director of the Provincial Productivity Promotion Center, Ding Lixin, Deputy Director of the Suzhou Industrial Park Management Committee, and leaders of the district committee attended the meeting, At the meeting, Ms. Wu Qiuting, on behalf of Aiwo Medical, extended a warm welcome to Professor Michael Rosbash, the Nobel Prize winner, and pointed out that Michael Professor Rosbash and other professors have made great contributions to medicine by discovering the molecular mechanisms that control circadian rhythms, and have therefore won the Nobel Prize in physiology or medicine. Aiwo Medical has been committed to building a communication and cooperation platform between Chinese hospitals and top international medical institutions, providing more assistance to Chinese hospitals in talent cultivation, medical quality, and discipline construction.

Zhao Zhiqiang, Director of the Provincial Productivity Promotion Center, and Ding Lixin, Deputy Director of the Suzhou Industrial Park Management Committee, delivered speeches and pointed out that Suzhou, China, is rapidly developing, and it is very important to carry out international exchanges and cooperation. We hope to strengthen the international development of health in Suzhou with the strong assistance of Aiwo Medical.

Michael Professor Rosbash, on behalf of the experts, expressed his sincere gratitude to Aiwo Medical and the leaders of the provincial and urban areas for their warm reception. He expressed his deep impression on Suzhou and hoped that Suzhou would become stronger and stronger in scientific research, and looked forward to long-term, stable, and cooperative development with Aiwo Medical.

Subsequently, the two sides spoke freely and asked questions to conduct exchanges and discussions on medical research between China and the United States.

Professor Michael Rosbash Winner of the 2017 Nobel Prize in Medicine and Physiology

National Academy of Sciences

Professor of Biology, Brandeis University, USA

Howard Hughes Institute of Medicine Researcher

Won the Willie Biomedical Science Award in 2013

2012 Peter Gruber Chair in Neuroscience

Awarded the Marsley Award in 2012

Won the Canadian Galdner International Award in 2012

Received the Louisa Gross Horwitz Award from Columbia University in 2011

Received the Gruber Prize for Mental Science in 2009

Received the California Institute of Technology Outstanding Alumni Award in 2001

1974-1980 Successively won the American Academy of Health Research Career Development Award

Professor Yuan Junying, Molecular Biologist

National Academy of Sciences

Academician of the American Academy of Arts and Sciences

Tenured professor at Harvard Medical School

Director of the Interdisciplinary Research Center of Biology and Chemistry, Chinese Academy of Sciences

The world's first gene discoverer of apoptosis

Editorial member of Cell Death&Diseases

Editorial member of Journal of Cell Biology

Received the SCBA Outstanding Young Researcher Award in 1999

Won the breast cancer research innovation award in 2002

Won the International Cell Death Association Award in 2006

Awarded the Agilent Thought Leader Award in 2013

Professor Elizabeth D. Hay of Harvard University in 2014

Professor Yu Qiang, postdoctoral fellow of Massachusetts Institute of Technology, professor of Boston University School of Medicine, and research team leader of Chinese Academy of Sciences Shanghai Institute of Materia Medica, is mainly engaged in cell biology and molecular biology research.

This time, Michael The visits of Rosbash and other provincial and municipal leaders demonstrate that Aiwo Medical is gradually increasing its popularity and credibility in the industry. Aiwo will also actively expand to provide cooperation platforms for health and medical institutions in more regions of China, strengthen communication with the world's top medical and health institutions, continuously improve management level and professional skills, and promote the development of China's health industry.